当前位置:首页 » 翻译 
  • 匿名
关注:1 2013-05-23 12:21

求翻译:Although the progress of the art and science of anaesthesia can be viewed as a gradual process since Morton's first anaesthetic in 1846, there was without doubt a quantum leap in 1942 -when Griffith and Johnson introduced curare into clinical practice . Neuromuscular blocking drugs (NMBs) have been in routine use since then but the search for the ideal NMB is almost as old as the story of NMBs itself, for curare had a slow onset, a long duration and a number of undesirable side effects. Progress in the management of neuromuscular blockade has inevitably been intermittent rather than continuous, as the development of this important aspect of anaesthetic practice is dependent on the introduction of new drugs. With each new drug, the management of neuromuscular blockade takes a step forwards, sideways, and occasionally even back a little. This supplement aims to outline the state of the art as it stands today and to ask whether the introduction of sugam-madex, the latest drug in the story of neuromuscularpharmacology, will drive the art and science forwards, sideways or back -is it really time for a change?#是什么意思?

待解决 悬赏分:1 - 离问题结束还有
Although the progress of the art and science of anaesthesia can be viewed as a gradual process since Morton's first anaesthetic in 1846, there was without doubt a quantum leap in 1942 -when Griffith and Johnson introduced curare into clinical practice . Neuromuscular blocking drugs (NMBs) have been in routine use since then but the search for the ideal NMB is almost as old as the story of NMBs itself, for curare had a slow onset, a long duration and a number of undesirable side effects. Progress in the management of neuromuscular blockade has inevitably been intermittent rather than continuous, as the development of this important aspect of anaesthetic practice is dependent on the introduction of new drugs. With each new drug, the management of neuromuscular blockade takes a step forwards, sideways, and occasionally even back a little. This supplement aims to outline the state of the art as it stands today and to ask whether the introduction of sugam-madex, the latest drug in the story of neuromuscularpharmacology, will drive the art and science forwards, sideways or back -is it really time for a change?#
问题补充:

  • 匿名
2013-05-23 12:26:38
麻醉科学和艺术的进展可被视为一个渐进的过程莫顿的第一次麻醉自 1846 年,虽然有无疑是一个飞跃 1942-当格里菲斯和约翰逊介绍的临床实践的箭。神经肌肉阻滞药物 (NMBs) 有被例程中使用以来然后搜索但本身,理想的基准是几乎一样古老的故事 NMBs 箭毒了缓发性、 长时间的持续时间和大量的不良副作用。肌松管理方面的进展无可避免地一直间歇性的而不是连续的因为这个重要的麻醉实践的发展依赖的新药介绍。每个新的药物与肌松管理需要迈出的一步向前、 向侧面,有时甚至回有点。此补充旨在概述艺术状态,按目前,并询问是否引入 sugam-madex,neuromuscularpharmacology,故事中的最新药物将推动艺术和科学向前、 向侧面或回-是真的时间变化? #
 
 
网站首页

湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区

 
关 闭